Rowe AS - Search Results

1

Risk factors for discharge on a new antipsychotic medication after admission to an intensive care unit.

Rowe AS, Hamilton LA, Curtis RA, Davis CR, Smith LN, Peek GK, Reynolds VW. Rowe AS, et al. J Crit Care. 2015 Dec;30(6):1283-6. doi: 10.1016/j.jcrc.2015.08.009. Epub 2015 Aug 18. J Crit Care. 2015. PMID: 26383104

2

A multicenter study of the point prevalence of drug-induced hypotension in the ICU.

Kane-Gill SL, LeBlanc JM, Dasta JF, Devabhakthuni S; Critical Care Pharmacotherapy Trials Network. Kane-Gill SL, et al. Crit Care Med. 2014 Oct;42(10):2197-203. doi: 10.1097/CCM.0000000000000499. Crit Care Med. 2014. PMID: 25014064

3

Management of apixaban-associated subdural hematoma: a case report on the use of factor eight inhibitor bypassing activity.

Rinehart DR, Lockhart NR, Hamilton LA, Langdon JR, Rowe AS. Rinehart DR, et al. Among authors: rowe as. Crit Care Med. 2015 Jun;43(6):e203-7. doi: 10.1097/CCM.0000000000000909. Crit Care Med. 2015. PMID: 25738855

4

Activated Prothrombin Complex Concentrate versus Plasma for Reversal of Warfarin-Associated Hemorrhage.

Rowe AS, Mahbubani PS, Bucklin MH, Clark CT, Hamilton LA. Rowe AS, et al. Pharmacotherapy. 2016 Nov;36(11):1132-1137. doi: 10.1002/phar.1848. Pharmacotherapy. 2016. PMID: 27726162

5

Activated Prothrombin Complex Concentrate Versus 4-Factor Prothrombin Complex Concentrate for Vitamin K-Antagonist Reversal.

Rowe AS, Dietrich SK, Phillips JW, Foster KE, Canter JR. Rowe AS, et al. Crit Care Med. 2018 Jun;46(6):943-948. doi: 10.1097/CCM.0000000000003090. Crit Care Med. 2018. PMID: 29498942

6

Contrast-Induced Nephropathy in Ischemic Stroke Patients Undergoing Computed Tomography Angiography: CINISter Study.

Rowe AS, Hawkins B, Hamilton LA, Ferrell A, Henry J, Wiseman BF, Skovran SA, Mosadegh MS, Hare ME, Kocak M, Tolley E. Rowe AS, et al. J Stroke Cerebrovasc Dis. 2019 Mar;28(3):649-654. doi: 10.1016/j.jstrokecerebrovasdis.2018.11.012. Epub 2018 Dec 7. J Stroke Cerebrovasc Dis. 2019. PMID: 30527789

7

Identification of Risk Factors for Refractory Status Epilepticus.

Tatro HA, Hamilton LA, Peters C, Rowe AS. Tatro HA, et al. Among authors: rowe as. Ann Pharmacother. 2020 Jan;54(1):14-21. doi: 10.1177/1060028019867155. Epub 2019 Jul 26. Ann Pharmacother. 2020. PMID: 31347376

8

Analysis of anticoagulation reversal survey (ARES).

Rowe AS, Dietrich S, Hamilton LA. Rowe AS, et al. Hosp Pract (1995). 2020 Aug;48(3):123-127. doi: 10.1080/21548331.2020.1753435. Epub 2020 Apr 15. Hosp Pract (1995). 2020. PMID: 32295428

9

23.4% Sodium Chloride Versus Mannitol for the Reduction of Intracranial Pressure in Patients With Traumatic Brain Injury: A Single-Center Retrospective Cohort Study.

Tatro HA, McMillen JC, Hamilton LA, Rowe AS. Tatro HA, et al. Among authors: rowe as. Ann Pharmacother. 2021 Aug;55(8):988-994. doi: 10.1177/1060028020982379. Epub 2020 Dec 21. Ann Pharmacother. 2021. PMID: 33345546

10

Patient-Specific Risk Factors Associated With the Development of Hyperchloremia in a Neurocritical Care Intensive Care Unit.

Hamilton LA, Behal ML, Carter AR, Rowe AS. Hamilton LA, et al. Among authors: rowe as. J Pharm Pract. 2023 Feb;36(1):110-116. doi: 10.1177/08971900211026840. Epub 2021 Jun 22. J Pharm Pract. 2023. PMID: 34155934

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters